Thus, this supports our study by showing that genotypic changes and MMP-2 and MMP-9 gene polymorphism may influence the expression of MMP-2 and MMP-9 in SAP patients and thereby affected the efficacy of UTI. The gene discussed is MMP9; the disease is bacterial urinary tract infection.